|
End-of-day quote
Shenzhen S.E.
2026-10-22
|
5-day change | 1st Jan Change | ||
| 7.710 CNY | -2.41% |
|
-5.40% | -10.76% |
Company Valuation: LanZhou Foci Pharmaceutical Co.,Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,615 | 5,127 | 4,764 | 4,979 | 3,942 | 4,412 |
| Change | - | 41.81% | -7.07% | 4.5% | -20.82% | 11.92% |
| Enterprise Value (EV) 1 | 3,264 | 4,812 | 4,421 | 4,625 | 3,585 | 3,933 |
| Change | - | 47.44% | -8.14% | 4.63% | -22.49% | 9.7% |
| P/E | 32.3x | 55x | 45x | 74.1x | 65.6x | 89.6x |
| PBR | 2.27x | 3.18x | 2.78x | 2.85x | 2.2x | 2.41x |
| PEG | - | -3.3x | 3.3x | -2x | -6.2x | -5x |
| Capitalization / Revenue | 5.41x | 6.27x | 4.67x | 4.28x | 4.02x | 4.82x |
| EV / Revenue | 4.89x | 5.89x | 4.34x | 3.98x | 3.66x | 4.3x |
| EV / EBITDA | 56.6x | 51.4x | 40x | 40.5x | 38.2x | 31.9x |
| EV / EBIT | 172x | 105x | 71.6x | 73.5x | 81.2x | 56.6x |
| EV / FCF | -17.4x | -144x | -166x | 76.4x | -376x | 26.8x |
| FCF Yield | -5.73% | -0.7% | -0.6% | 1.31% | -0.27% | 3.73% |
| Dividend per Share 2 | 0.12 | 0.01 | 0.05 | 0.03 | 0.012 | 0.02 |
| Rate of return | 1.69% | 0.1% | 0.54% | 0.31% | 0.16% | 0.23% |
| EPS 2 | 0.2193 | 0.1826 | 0.2075 | 0.1316 | 0.1176 | 0.0964 |
| Distribution rate | 54.7% | 5.48% | 24.1% | 22.8% | 10.2% | 20.7% |
| Net sales 1 | 668.1 | 817.6 | 1,019 | 1,163 | 980.2 | 915.5 |
| EBITDA 1 | 57.63 | 93.58 | 110.6 | 114.3 | 93.76 | 123.5 |
| EBIT 1 | 18.94 | 45.65 | 61.73 | 62.9 | 44.13 | 69.47 |
| Net income 1 | 112 | 93.26 | 105.9 | 67.19 | 60.07 | 49.21 |
| Net Debt 1 | -351.5 | -314.6 | -343.7 | -353.4 | -357.1 | -479 |
| Reference price 2 | 7.080 | 10.040 | 9.330 | 9.750 | 7.720 | 8.640 |
| Nbr of stocks (in thousands) | 510,657 | 510,657 | 510,657 | 510,657 | 510,657 | 510,657 |
| Announcement Date | 4/15/21 | 3/15/22 | 3/30/23 | 4/9/24 | 4/25/25 | 4/8/26 |
1CNY in Million2CNY
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 604M | |
| 36.67x | 13.07x | 27.74x | 0.54% | 1,133B | |
| 37.73x | 6.36x | 17.89x | 2.07% | 621B | |
| 36.35x | 8.36x | 17.26x | 2.41% | 503B | |
| 21.21x | 5.12x | 12.74x | 2.55% | 379B | |
| 109.25x | 6.09x | 26.14x | 2.27% | 370B | |
| 21.57x | 5.62x | 13.82x | 2.84% | 292B | |
| 22.08x | 4.46x | 12.77x | 1.98% | 262B | |
| 27.83x | 7.14x | 12.79x | 2.3% | 237B | |
| -44.76x | 6.88x | 26.67x | 2.15% | 190B | |
| Average | 29.77x | 7.01x | 18.64x | 2.12% | 398.86B | |
| Weighted average by Cap. | 35.57x | 8.27x | 20.36x | 1.81% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 002644 Stock
- Valuation LanZhou Foci Pharmaceutical Co.,Ltd.
Select your edition
All financial news and data tailored to specific country editions
